Vivex Biologics launches bone graft substitutes

Vivex Biologics launched its Via Mend synthetic bone fillers, a line of bone graft substitutes, the company announced July 15.

Advertisement

The bone graft substitutes come in the form of a bioactive implant and a moldable biocomposite putty. The bioactive strip implant is made of carbonate apatite bone mineral, purified collagen and bioactive glass. The putty can be molded when hydrated with autogenous bone marrow.

Vivex Biologics focuses on regenerative medicine.

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.